Onderneming Biotoscana Investments S.A.
Aandelen
GBIO33
BRGBIOBDR008
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Claudio Coracini
CEO | Chief Executive Officer | - | 21-10-19 |
Director of Finance/CFO | - | 15-08-19 | |
Ivan French
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-17 |
Román Saglio
SAM | Sales & Marketing | 54 | 01-01-15 |
Renato de Giorgi
PRN | Corporate Officer/Principal | 55 | 01-01-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Lande
BRD | Director/Board Member | 61 | 25-11-19 |
Samira Sakhia
CHM | Chairman | 55 | 29-11-19 |
Gaëlle Lamotte
BRD | Director/Board Member | - | 25-11-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 106 622 306 | 104 688 619 ( 98,19 %) | 490 236 ( 0,4598 %) | 98,19 % |
Bedrijfsgegevens
Biotoscana Investments SA
WTC Montevideo Free Zone Dr Luis Bonavita, 1294
11300, Montevideo
+
http://www.grupobiotoscana.com![Adres Biotoscana Investments S.A.(GBIO33)](https://cdn.zonebourse.com/static/address/37215933.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,90% | 71,83 mld. | |
+22,78% | 9,56 mld. | |
+30,09% | 4,85 mld. | |
-21,31% | 4,48 mld. | |
+24,78% | 3,9 mld. | |
+11,03% | 2,01 mld. | |
-2,11% | 1,99 mld. | |
-36,28% | 1,89 mld. | |
-43,19% | 1,77 mld. |